心房功能性二尖瓣反流:外科修复与TEER的荟萃分析比较
TEER组患者年龄更大、NYHA III/IV症状比例及STS评分更高。随访3.2年时,外科修复与晚期重度MR、全因死亡、心衰住院及NYHA III/IV发生率降低相关,但异质性高,结论为假设生成性。
要点
- TEER患者较外科组平均年长10岁,NYHA III/IV症状率及STS评分均更高。
- 随访3.2年,外科修复与晚期重度MR、全因死亡、心衰住院及NYHA III/IV发生率降低相关。
- 早期全因死亡、心脏特异性死亡及术后并发症两组无差异,结论需前瞻性研究验证。
核心结论
- 外科修复与TEER短期结局相当,外科修复长期结局更优,但因研究局限及异质性,结论为假设生成性。
研究设计与样本
- 检索MEDLINE、EMBASE和Cochrane Library,采用随机效应模型,行留一法、亚组及荟萃回归分析。
主要发现
- TEER组平均年长10岁,NYHA III/IV症状率为外科组两倍,STS评分超过两倍。
- 早期全因死亡、早期心脏特异性死亡、晚期心脏特异性死亡、术后并发症及心房直径两组无差异。
关键数值与推荐
- 主要结局为晚期重度MR发生率。
- 外科修复与晚期重度MR、全因死亡、心衰住院及NYHA III/IV发生率降低相关,但异质性高。
临床怎么用
- 对于心房功能性MR,外科修复可能提供更优长期结局,但需结合患者年龄、症状及STS评分个体化选择。
- TEER可作为高龄、高手术风险患者的选项,短期结局与外科相当。
局限性
- 研究存在局限性和高异质性,长期结局优势需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Atrial functional mitral regurgitation (MR) lacks well-defined treatment guidelines. Medical therapy alone is insufficient, and either TEER (transcatheter edge-to-edge) or surgery is recommended. Short- and long-term comparative outcomes remain unclear. We aim to address this gap using available data. METHODS: We performed a meta-analysis of studies examining the outcomes of surgery and/or transcatheter edge-to-edge. MEDLINE, EMBASE, and the Cochrane Library were assessed. The incidence rate of late severe MR was the primary outcome. A random model was performed. Leave-one-out, subgroup, and meta-regression analyses were conducted. RESULTS: Thirty-two studies (1923 patients); 20 in surgery (1166) vs 12 in TEER (757), were selected. TEER patients were, on average, 10 years older, with twice the rate of New York Heart Association Classification (NYHA) III/IV symptoms and more than double the Society of Thoracic Surgeons Risk (STS) score. At a weighted mean follow-up of 3.2 years, compared to isolated transcatheter, surgery was associated with decreased incidence of late severe MR (2.53 vs 6.66 events per 100 person-years, P-interaction = .03), late all-cause mortality (3.00 vs 8.84, P-interaction = .024), late heart failure hospitalization (4.44 vs 17.03, P-interaction < .01), and late NYHA III/IV (2.98 vs 22.47, P-interaction < .01). However, significantly better long-term outcomes associated with surgery showed high heterogeneity. There were no differences in early all-cause mortality, early cardiac-specific mortality, late cardiac-specific mortality, postprocedural morbidities, or atrial diameter. On meta-regression, preprocedural heart failure (β = 0.0224, P < .01) and coronary artery disease (β = 0.0294, P < .00001) were linked to increased late severe MR. Older age, hypertension, mitral valve replacement, and associated aortic valve surgery were linked to increased late all-cause mortality. CONCLUSIONS: Surgery and isolated transcatheter edge-to-edge repair showed comparable short-term outcomes, with surgery appearing more effective long-term; however, due to study limitations and heterogeneity, these findings are hypothesis-generating and require validation through prospective studies. CLINICAL REGISTRATION NUMBER: PROSPERO website: CRD42024504022.
引用
- Khairallah S, Rahouma M, Demetres M, et al. Comparison of Meta-Analytical Estimates Between Surgical Repair and Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 41442445. doi:10.1093/icvts/ivaf269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。